InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology

Quality Policy

"InterVenn is driven by providing innovative products and solutions to our customers through our holistic understanding of glycoproteomics, other post-translational modifications, and health.

We are committed to set patient care at the core of everything we do, meet the needs of our employees, provide data integrity to scientists and clinicians, comply with regulatory requirements, engage in continuous improvement, and maintain an effective quality management system."

Get in touch